Generation of a recessive dystrophic epidermolysis bullosa mouse model with patient-derived compound heterozygous mutations

• Published in: Laboratory investigation 2022-06, Vol.102 (6), p.574-580
• Main Authors: Takaki, Satoshi, Shimbo, Takashi, Ikegami, Kentaro, Kitayama, Tomomi, Yamamoto, Yukari, Yamazaki, Sho, Mori, Shiho, Tamai, Katsuto
• Format: Article
• Language: English
• Subjects: 13/51; 38/91; 631/208/737; 631/61/17; 64/60; Abnormalities; Animal models; Animals; Cell cycle; Chromosomes; Collagen (type VII); Collagen Type VII - genetics; CRISPR; Disease Models, Animal; Dystrophic epidermolysis bullosa; Dystrophy; Editing; Epidermolysis bullosa; Epidermolysis Bullosa Dystrophica - genetics; Epidermolysis Bullosa Dystrophica - pathology; Gene sequencing; Genes, Recessive; Genetic disorders; Genome editing; Genomes; Homozygote; Humans; Keratinocytes; Laboratory Medicine; Life span; Medicine; Medicine & Public Health; Mice; Mutation; Pathogenesis; Pathology; Patients; Phenotype; Phenotypes; Rodents; Skin diseases; Syndactyly
• ISSN: 0023-6837; 1530-0307
• DOI: 10.1038/s41374-022-00735-5

Recessive dystrophic epidermolysis bullosa (RDEB) is an intractable genetic disease of the skin caused by mutations in the COL7A1 gene. The majority of patients with RDEB harbor compound heterozygous mutations—two distinct mutations on each chromosome—without any apparent hotspots in the COL7A1 mutation pattern. This situation has made it challenging to establish a reliable RDEB mouse model with mutations that accurately mimic the genomic background of patients. Here, we established an RDEB mouse model harboring patient-type mutations in a compound heterozygous manner, using the CRISPR-based genome-editing technology i-GONAD. We selected two mutations, c.5818delC and E2857X, that have frequently been identified in cohorts of Japanese patients with RDEB. These mutations were introduced into the mouse genome at locations corresponding to those identified in patients. Mice homozygous for the 5818delC mutation developed severe RDEB-like phenotypes and died immediately after birth, whereas E2857X homozygous mice did not have a shortened lifespan compared to wild-type mice. Adult E2857X homozygous mice showed hair abnormalities, syndactyly, and nail dystrophy; these findings indicate that E2857X is indeed pathogenic in mice. Mice with the c.5818delC/E2857X compound heterozygous mutation presented an intermediate phenotype between the c.5818delC and E2857X homozygous mice. Single-cell RNA sequencing further clarified that the intrafollicular keratinocytes in c.5818delC/E2857X compound heterozygous mice exhibited abnormalities in cell cycle regulation. The proposed strategy to produce compound heterozygous mice, in addition to the established mouse line, will facilitate research on RDEB pathogenesis to develop a cure for this devastating disease. Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic skin disease caused by mutations in the gene COL7A1 . The authors developed a strategy to investigate the impact of each pathogenic mutation on skin integrity using CRISPR-mediated genome editing in mice in order to create a reliable animal model for the study of this devastating disease.